InsidersTradesSigma
Discover the detailed record of transactions filed by Kelly Scott A., Président. Director active across 1 companies, notably CytoDyn Inc.. Aggregated, 4 disclosures have been logged. The latest transaction was filed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Scott A. Kelly is the Chairman and Chief Medical Officer at CytoDyn Inc. He leads the company and oversees medical initiatives. Scott plays a key role in developing new treatments and achieving the company's objectives.